209 related articles for article (PubMed ID: 31884373)
1. Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing.
Nur Patria Y; Lilianty J; Elefanty AG; Stanley EG; Labonne T; Bateman JF; Lamandé SR
Stem Cell Res; 2020 Jan; 42():101689. PubMed ID: 31884373
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 gene editing of a SOX9 reporter human iPSC line to produce two TRPV4 patient heterozygous missense mutant iPSC lines, MCRIi001-A-3 (TRPV4 p.F273L) and MCRIi001-A-4 (TRPV4 p.P799L).
Nur Patria Y; Stenta T; Lilianty J; Rowley L; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
Stem Cell Res; 2020 Oct; 48():101942. PubMed ID: 32771907
[TBL] [Abstract][Full Text] [Related]
3. Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing.
Hosseini Far H; Patria YN; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
Stem Cell Res; 2019 May; 37():101449. PubMed ID: 31075690
[TBL] [Abstract][Full Text] [Related]
4. Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing.
Houweling PJ; Crossman V; Tiong CF; Coles CA; Taylor RL; Clayton JS; Graham A; Vlahos K; Howden SE; North KN
Stem Cell Res; 2024 Mar; 75():103313. PubMed ID: 38277710
[TBL] [Abstract][Full Text] [Related]
5. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing.
Lilianty J; Nur Patria Y; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
Stem Cell Res; 2020 May; 45():101843. PubMed ID: 32446218
[TBL] [Abstract][Full Text] [Related]
6. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing.
Zhao H; He L; Huang H; Li S; Cheng N; Tang F; Han X; Lin Z; Huang R; Zhou P; Deng S; Huang J; Li Z
Stem Cell Res; 2020 Oct; 48():102003. PubMed ID: 32977294
[TBL] [Abstract][Full Text] [Related]
7. Generation of an ESRG Pr-tdTomato reporter human embryonic stem cell line, CSUe011-A, using CRISPR/Cas9 editing.
Liu H; Li S; Ren C; Liu W; Zhu B; Wang L; Xu H; Xie W; Zuo X; Zhou Y; Luo L; Jiang X
Stem Cell Res; 2020 Oct; 48():101983. PubMed ID: 32919352
[TBL] [Abstract][Full Text] [Related]
8. Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing.
Tsukamoto S; Nakade K; Wakabayashi T; Nakashima K; Takami M; Hemmi Y; Kuramochi Y; Shimizu T; Arai Y; Matsuo-Takasaki M; Noguchi M; Nakamura Y; Miwa Y; Hayashi Y
Stem Cell Res; 2021 May; 53():102363. PubMed ID: 34087992
[TBL] [Abstract][Full Text] [Related]
9. Generation of a NESTIN-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease.
Lee Y; Choi HY; Kwon A; Park H; Park M; Kim YO; Kwak S; Koo SK
Stem Cell Res; 2019 Oct; 40():101554. PubMed ID: 31499408
[TBL] [Abstract][Full Text] [Related]
10. Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing.
Lilianty J; Bateman JF; Lamandé SR
Stem Cell Res; 2021 Oct; 56():102515. PubMed ID: 34543885
[TBL] [Abstract][Full Text] [Related]
11. Generation of a
Nouri P; Zimmer A; Brüggemann S; Friedrich R; Kühn R; Prakash N
Cells; 2022 Jan; 11(2):. PubMed ID: 35053384
[TBL] [Abstract][Full Text] [Related]
12. Generation of a gene edited hemophilia A patient-derived iPSC cell line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII using CRISPR/Cas9.
Sung JJ; Park S; Choi SH; Kim J; Cho MS; Kim DW
Stem Cell Res; 2020 Oct; 48():101948. PubMed ID: 32798916
[TBL] [Abstract][Full Text] [Related]
13. Generation of Brachyury-mCherry knock-in reporter human pluripotent stem cell line (SNUe003-A-2) using CRISPR/CAS9 nuclease.
Jung J; Hwang S; Seol H; Kim AH; Lee HM; Sung JJ; Jeong SM; Choi YM; Jun JK; Kim DW; Jang J
Stem Cell Res; 2021 May; 53():102321. PubMed ID: 33878708
[TBL] [Abstract][Full Text] [Related]
14. The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line.
Howden S; Hosseini Far H; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
Stem Cell Res; 2019 Jul; 38():101453. PubMed ID: 31082677
[TBL] [Abstract][Full Text] [Related]
15. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
[TBL] [Abstract][Full Text] [Related]
16. Generation of human GAPDH knock-in reporter iPSC lines for stable expression of tdTomato in pluripotent and differentiated culture conditions.
Kamiya D; Yamashita T; Akaboshi T; Yamaguchi Y; Toyooka Y; Ikeya M
Stem Cell Res; 2022 Apr; 60():102704. PubMed ID: 35176664
[TBL] [Abstract][Full Text] [Related]
17. Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing.
Diouf D; Vitale MR; Zöller JEM; Pineau AM; Klopocki E; Hamann C; Ziegler GC; Vanmierlo T; Van den Hove D; Lesch KP
Stem Cell Res; 2023 Mar; 67():103038. PubMed ID: 36746102
[TBL] [Abstract][Full Text] [Related]
18. Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9.
Fatima A; Schuster J; Akram T; Sobol M; Hoeber J; Dahl N
Stem Cell Res; 2020 Apr; 44():101758. PubMed ID: 32203915
[TBL] [Abstract][Full Text] [Related]
19. Incontinentia pigmenti: Generation of an IKBKG deficient human iPSC line (KICRi002-A-1) on a 46,XY background using CRISPR/Cas9.
Fatima A; Schuster J; Akram T; González CM; Sobol M; Hoeber J; Dahl N
Stem Cell Res; 2020 Apr; 44():101739. PubMed ID: 32126327
[TBL] [Abstract][Full Text] [Related]
20. Generation of two isogenic knockout PKD2 iPS cell lines, IRFMNi003-A-1 and IRFMNi003-A-2, using CRISPR/Cas9 technology.
Trionfini P; Ciampi O; Romano E; Benigni A; Tomasoni S
Stem Cell Res; 2020 Jan; 42():101667. PubMed ID: 31830647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
